Structural Basis for Targeting of Human RNA Helicase DDX3 by Poxvirus Protein K7

Structure

Volumn 17, Issue 11, 2009, Pages 1528-1537

  Oda, Shun ichiro ^a   Schröder, Martina ^b   Khan, Amir R ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

MICROBIO; PROTEINS; RNA

Indexed keywords

BETA INTERFERON; K7 PROTEIN; PHENYLALANINE; PROTEIN BCL 2; PROTEIN DDX3; RNA HELICASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME INDUCTION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN STRUCTURE; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLIZATION; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; SEQUENCE ALIGNMENT; TNF RECEPTOR-ASSOCIATED FACTOR 6; VACCINIA VIRUS; VIRAL PROTEINS;

DNA VIRUSES; POXVIRIDAE; VACCINIA VIRUS;

EID: 70350738244     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2009.09.005     Document Type: Article

References (41)

1. Aoyagi M., Zhai D., Jin C., Aleshin A., Stec B., Reed J., and Liddington R. Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci. 16 (2007) 118-124
2. Ariumi Y., Kuroki M., Abe K., Dansako H., Ikeda M., Wakita T., and Kato N. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 81 (2007) 13922-13926
3. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., and O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97 (2000) 10162-10167
4. Bowie A.G., and Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8 (2008) 911-922
5. Cooray S., Bahar M.W., Abrescia N.G., McVey C.E., Bartlett N.W., Chen R.A., Stuart D.I., Grimes J.M., and Smith G.L. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J. Gen. Virol. 88 (2007) 1656-1666
6. Cullen B.R. Human immunodeficiency virus: nuclear RNA export unwound. Nature 433 (2005) 26-27
7. Day C.L., Chen L., Richardson S.J., Harrison P.J., Huang D.C., and Hinds M.G. Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands. J. Biol. Chem. 280 (2005) 4738-4744
8. Day C.L., Smits C., Fan F.C., Lee E.F., Fairlie W.D., and Hinds M.G. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 380 (2008) 958-971
9. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60 (2004) 2126-2132
10. Graham S.C., Bahar M.W., Cooray S., Chen R.A., Whalen D.M., Abrescia N.G., Alderton D., Owens R.J., Stuart D.I., Smith G.L., and Grimes J.M. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 4 (2008) e1000128
11. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., and O'Neill L.A. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
12. Hogbom M., Collins R., van den Berg S., Jenvert R.M., Karlberg T., Kotenyova T., Flores A., Hedestam G.B., and Schiavone L.H. Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3 in complex with the mononucleotide AMP. J. Mol. Biol. 372 (2007) 150-159
13. Kalverda A.P., Thompson G.S., Vogel A., Schroder M., Bowie A.G., Khan A.R., and Homans S.W. Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J. Mol. Biol. 385 (2009) 843-853
14. Keating S.E., Maloney G.M., Moran E.M., and Bowie A.G. IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J. Biol. Chem. 282 (2007) 33435-33443
15. Kvansakul M., van Delft M.F., Lee E.F., Gulbis J.M., Fairlie W.D., Huang D.C., and Colman P.M. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 25 (2007) 933-942
16. Kwong A.D., Rao B.G., and Jeang K.T. Viral and cellular RNA helicases as antiviral targets. Nat. Rev. Drug Discov. 4 (2005) 845-853
17. Lardone M.C., Parodi D.A., Valdevenito R., Ebensperger M., Piottante A., Madariaga M., Smith R., Pommer R., Zambrano N., and Castro A. Quantification of DDX3Y, RBMY1, DAZ and TSPY mRNAs in testes of patients with severe impairment of spermatogenesis. Mol. Hum. Reprod. 13 (2007) 705-712
18. Liu X., Dai S., Zhu Y., Marrack P., and Kappler J. The structure of a Bcl-xl/Bim fragment complex: Implications for Bim function. Immunity 19 (2003) 341-352
19. Liu X., Dai S., Zhu Y., Marrack P., and Kappler J.W. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 19 (2003) 341-352
20. Maloney G., Schroder M., and Bowie A.G. Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10. J. Biol. Chem. 280 (2005) 30838-30844
21. McCoy S.L., Kurtz S.E., Macarthur C.J., Trune D.R., and Hefeneider S.H. Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation. J. Immunol. 174 (2005) 3006-3014
22. Moynagh P.N. The NF-kappaB pathway. J. Cell Sci. 118 (2005) 4589-4592
23. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
24. O'Neill L.A. Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Curr. Opin. Immunol. 18 (2006) 3-9
25. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
26. Owsianka A.M., and Patel A.H. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257 (1999) 330-340
27. Perrakis A., Harkiolaki M., Wilson K.S., and Lamzin V.S. ARP/wARP and molecular replacement. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 1445-1450
28. Petros A.M., Medek A., Nettesheim D.G., Kim D.H., Yoon H.S., Swift K., Matayoshi E.D., Oltersdorf T., and Fesik S.W. Solution structure of the antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 98 (2001) 3012-3017
29. Petros A.M., Olejniczak E.T., and Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644 (2004) 83-94
30. Rosner A., and Rinkevich B. The DDX3 subfamily of the DEAD box helicases: divergent roles as unveiled by studying different organisms and in vitro assays. Curr. Med. Chem. 14 (2007) 2517-2525
31. Sattler M., Liang H., Nettesheim D., Meadows R., Harlan J., Eberstadt M., Yoon H., Shuker S., Chang B., Minn A., et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
32. Schroder M., Baran M., and Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27 (2008) 2147-2157
33. Sengoku T., Nureki O., Nakamura A., Kobayashi S., and Yokoyama S. Structural basis for RNA unwinding by the DEAD-box protein Drosophila Vasa. Cell 125 (2006) 287-300
34. Sheldrick G.M. A short history of SHELX. Acta Crystallogr. A 64 (2008) 112-122
35. Shih J.W., Tsai T.Y., Chao C.H., and Wu Lee Y.H. Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein. Oncogene 27 (2008) 700-714
36. Smith G.L., Chan Y.S., and Howard S.T. Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. J. Gen. Virol. 72 (1991) 1349-1376
37. Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., Hantschel O., Bennett K.L., Decker T., and Superti-Furga G. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27 (2008) 2135-2146
38. Stack J., Haga I., Schroder M., Bartlett N., Maloney G., Reading P., Fitzgerald K., Smith G., and Bowie A. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 201 (2005) 1007-1018
39. Takaoka A., and Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv. Drug Deliv. Rev. 60 (2008) 847-857
40. Wang H., Kim S., and Ryu W.S. DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 83 (2009) 5815-5824
41. Yedavalli V.S.R.K., Neuveut C., Chi Y.H., Kleiman L., and Jeang K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 REV-RRE export function. Cell 119 (2004) 381-392